#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fungal infection Adenovirus infection Neoplasm malignant Philadelphia chromosome positive Propionic acidaemia Leiomyosarcoma recurrent Metastases to peritoneum Deafness Amyotrophic lateral sclerosis gene carrier Mantle cell lymphoma Sjogren's syndrome Bulbospinal muscular atrophy congenital Loss of consciousness Measles Mucopolysaccharidosis III More trials…

    Learn about Rare Diseases

    Cystic fibrosis lung – Diagnostics Glomerulonephritis membranous – Trials in Disease Shprintzen-Goldberg syndrome – Life with Disease Pemphigoid – Life with Disease Rhabdomyosarcoma – Treatment Haemophilia Haemophilia A without inhibitors – Treatment Amyotrophic lateral sclerosis – Diagnostics Netherton’s syndrome – Life with Disease Metachromatic leukodystrophy – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Briquilimab Crizotinib IHMA-2121908-1 Abc-35B-116 SPY002 Lovotibeglogene Autotemcel Demeclocycline Hydrochloride Zasocitinib Ficlatuzumab Levocetirizine Dihydrochloride Patisiran Ademetionine XYLOMETAZOLINE HYDROCHLORIDE Pentixafor Mk-1200 Pal1-15 Acetate Sertindole Follitropin Alfa Clomipramine Hydrochloride Selpercatinib More therapies…

    Learn about Your Condition

    Acromegaly Malignant glioma Haemodialysis Noninfective chorioretinitis Thymoma Dilated cardiomyopathy SAPHO syndrome Alpha-1 antitrypsin deficiency Osteomyelitis Meniscus operation Acarodermatitis Marginal zone lymphoma Hydrocele Cortisol abnormal Extraskeletal ossification More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Mtnsnx Zqknfvdn Kjluk 2cz Dfboqrliv 4wzer Hucyyaj

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Favezelimab
    • Lenvatinib
    • Olaparib
    Austria Belgium Czechia Denmark Estonia Finland +15

  • Study on Human Serum Albumin and Sodium Chloride for Patients with Liver Cirrhosis and Ascites

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Human Serum Albumin
    • Sodium Chloride
    Belgium Denmark Germany Hungary The Netherlands Slovakia +1

  • Study on Ewing Sarcoma Treatment with Vinorelbine and Drug Combination for Patients with Primary and Disseminated Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ewing’s sarcoma
    Investigated Drugs:
    • Doxorubicin
    • Filgrastim
    • Ifosfamide
    Austria Belgium Finland Germany Greece Hungary +2

  • Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Goserelin
    • Leuprorelin
    • Triptorelin
    Austria Belgium Bulgaria Czechia France Germany +8

  • Study on TAK-330 for Reversing Anticoagulation in Patients on Factor Xa Inhibitors Needing Urgent Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Thrombosis prophylaxis
    Investigated Drugs:
    • Human Coagulation Factor Ii
    • Human Coagulation Factor Ix
    • Human Coagulation Factor Vii
    Austria Belgium Czechia France Germany Greece +5

  • Study on Human Normal Immunoglobulin and Sodium Chloride to Prevent Infections in Patients with Chronic Lymphocytic Leukemia

    Recruiting

    3 1 1
    Investigated Drugs:
    • Human Normal Immunoglobulin
    • Sodium Chloride
    Bulgaria Croatia Hungary Poland Romania

  • Long-Term Follow-Up Study for Patients Treated with Idecabtagene Vicleucel or Lisocabtagene Maraleucel for Cancer

    Recruiting

    4 1 1
    Investigated Drugs:
    • ARLOCABTAGENE AUTOLEUCEL
    • CC-97540
    • Idecabtagene Vicleucel
    Austria Belgium Czechia Denmark Finland France +11

  • Study Comparing Iberdomide and Lenalidomide for Maintenance Therapy After Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Warfarin Sodium
    • Acetylsalicylic Acid
    • Apixaban
    Austria Belgium Czechia Denmark Finland France +10

  • Study on the Effectiveness of Atenativ for Patients with Congenital Antithrombin Deficiency Undergoing Surgery or Childbirth

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Antithrombin III deficiency
    Investigated Drugs:
    • Antithrombin Iii Human
    • Human Plasma Derived Antithrombin
    Austria Czechia France Germany Hungary Italy +2

  • Study of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn’s Disease

    Recruiting

    2 1 1
    Investigated Drugs:
    • ABBV-8736
    • Humanised Igg1 Kappa Monoclonal Antibody Against Alfa4Beta7 Integrin
    • Lutikizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +17
Previous Page
1 … 15 16 17 18 19 … 52
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!